Digging into KKR’s $1.2b-plus deal for Lightyear’s Therapy Brands, Another big LBO opportunity emerges in Medline Industries

Behind KKR's $1.25 billion Therapy Brands' buyout and Medline Industries is exploring a sale that could value it as much as $30 billion.